Publications by authors named "I Korakis"

Claim this Profile
A
Addressing screening failures in early-phase clinical trials in oncology: impact on patient outcomes and strategies for improvement.
I Korakis, K Ouali, B Hanvic, L Verlingue, B Allignet

ESMO Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis.
Sophie Cousin, Jean-Philippe Guégan, Lola Jade Palmieri, Jean Philippe Metges, Simon Pernot, Iphigenie Korakis

Nat Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers.
Stephane Champiat, Elena Garralda, Vladimir Galvao, Philippe A Cassier, Carlos Gomez-Roca, Iphigenie Korakis

Cell Rep Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modernizing the assessment and reporting of adverse events in oncology clinical trials using complementary statistical approaches: a case study of the MOTIVATE trial.
Mathilde Morisseau, Carlos Gomez-Roca, Marie Viala, Audrey Rabeau, Delphine Loirat, Iphigenie Korakis

Invest New Drugs· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-edged sword: unusual multiple severe infections with pralsetinib: a case report and literature review.
François Poumeaud, Marion Jaffrelot, Carlos Gomez-Roca, Iphigénie Korakis, Giulia Leonardi

Front Med (Lausanne)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis